Progesterone Receptor Negative Completed Phase 2 Trials for Fludeoxyglucose (18F) (DB09502)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0259919418F-FSPG PET/CT for Cancer Patients on TherapyDiagnostic